Zobrazeno 1 - 4
of 4
pro vyhledávání: '"József Szász"'
Autor:
Elinor Ben‐Menachem, Jacqueline Dominguez, József Szász, Cynthia Beller, Charles Howerton, Lori Jensen, Carrie McClung, Robert Roebling, Björn Steiniger‐Brach
Publikováno v:
Epilepsia Open, Vol 6, Iss 3, Pp 618-623 (2021)
Abstract The primary objective of this trial (SP1042; NCT02582866) was to assess long‐term safety and tolerability of lacosamide monotherapy (200‐600 mg/day) in adults with focal (partial‐onset) seizures or generalized tonic‐clonic seizures (
Externí odkaz:
https://doaj.org/article/e81a1630b10d4915a70ef5863dd53e20
Autor:
Norbert Kovács, József Szász, Lydia Vela-Desojo, Per Svenningsson, Samira Femia, Juan Carlos Parra, Olga Sanchez-Soliño, Lars Bergmann, Tanya Gurevich, Alfonso Fasano
Publikováno v:
Parkinsonismrelated disorders. 105
Patients with advanced Parkinson's disease (APD) commonly experience motor and nonmotor symptoms (NMS) associated with functional limitations and decreased quality of life. We compared motor and nonmotor outcomes in patients with APD receiving 24- ve
Autor:
József, Szász, Szabolcs, Szatmári, Viorelia, Constantin, István, Mihály, Attila, Rácz, Imola, Török, Előd, Nagy, Krisztina, Kelemen, Timea, Forró, Beáta, Baróti, Károly, Orbán-Kis
Publikováno v:
Orvosi hetilap. 161(39)
Autor:
Jozsef Szasz, Mihaela Simu, Lacramioara Perju-Dumbrava, Angelo Antonini, Lars Bergmann, Diana Popescu, Ovidiu Alexandru Bajenaru
Publikováno v:
Romanian Journal of Neurology, Vol 19, Iss 1, Pp 27-35 (2020)
Objectives. The aim of the Global Long-Term Registry on Efficacy and Safety of DUODOPA in Patients with Advanced Parkinson’s Disease in Routine Care (GLORIA) was to document 24-month efficacy, safety and the effect on patient’s quality of life (Q
Externí odkaz:
https://doaj.org/article/8989d0553aee41e499c9ea7e8eb6ec0b